Second Sight Medical Products, Inc.(NASDAQ : EYES)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | 0.90% | 104.36 | 0.8% | $763.44m | |
| TMO | Thermo Fisher Scientific, Inc. | 0.85% | 426.01 | 1.0% | $628.17m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 673.73 | 2.4% | $492.93m | |
| MDT | Medtronic Plc | 0.98% | 104.20 | 0.6% | $486.23m | |
| DHR | Danaher Corp. | 0.01% | 207.18 | 0.7% | $449.88m | |
| BDX | Becton, Dickinson & Co. | 0.03% | 224.15 | 1.0% | $422.13m | |
| QDEL | Quidel Corp. | 0.00% | 196.77 | 7.7% | $403.46m | |
| DXCM | DexCom, Inc. | 1.23% | 407.30 | 7.9% | $323.01m | |
| SYK | Stryker Corp. | -0.14% | 204.73 | 1.3% | $282.17m | |
| BSX | Boston Scientific Corp. | 0.00% | 37.34 | 1.0% | $281.37m | |
| INO | Inovio Pharmaceuticals, Inc. | -36.01% | 10.84 | 5.9% | $266.30m | |
| VAR | Varian Medical Systems, Inc. | -0.01% | 171.98 | 9.1% | $257.67m | |
| BAX | Baxter International, Inc. | 0.01% | 79.65 | 1.8% | $246.33m | |
| EW | Edwards Lifesciences Corp. | 1.67% | 78.75 | 0.4% | $229.79m | |
| ALGN | Align Technology, Inc. | 0.00% | 317.93 | 6.4% | $227.19m |
Company Profile
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.